Long-Term Survival of Type XVII Collagen Revertant Cells in an Animal Model of Revertant Cell Therapy
July 2013
in “
Journal of Investigative Dermatology
”
Studysummary Revertant cell therapy shows promise for treating type XVII collagen deficiency, but better cell selection methods are needed.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on jidonline.org →